Home Tags Cannabis

Cannabis Related Content

CBD in the UK, dose

A comprehensive guide to CBD in the UK

Here, Professor Mike Barnes discusses and answers some key questions about the world of CBD in the UK.
Quality of medicinal cannabis, purely plant

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
series B equity financing, mile high

MHL Series B equity financing and global CPG partnerships

Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
import of medical cannabis, drug

The import of medical cannabis: Germany and the Netherlands

Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.
drug testing

Stop drug testing and start impairment testing

A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
CBD novel food applications

The European Commission’s ‘pause’ on CBD novel food applications

Associate, David Hardstaff and Partner, John Binns at BCL Solicitors LLP, explain here how cannabis wonder child takes a knock in light of the European Commission’s ‘pause’ on CBD novel food applications mean for this booming industry.
chronic pain diseases, cannabinoids

Chronic pain diseases and medical cannabis

Janosch Kratz discusses the importance of medical cannabis for chronic pain diseases.
THC in CBD, EUMCA

EUMCA: Limit of 0.2% THC in CBD products should not change

Chair of the European Medicinal Cannabis Association (EUMCA) issues warning that raising limit for THC in CBD to 0.3% will risk patient safety.
medical cannabis

How are different types of medical cannabis working for different diseases?

Dr David Moorhouse, General Neurologist, discusses the way that different diseases respond to different types of medical cannabis.
pain medicine

How cannabinoids can be used as pain medicine

Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.
access to medicinal cannabis, trevor jones

The EUMCA: Pioneering access to medicinal cannabis

Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
cannabinoid research

Expanding the portfolio of rigorous cannabinoid research with new funding opportunities

David Shurtleff, PhD, Deputy Director at the National Center for Complementary and Integrative Health, National Institutes of Health, discusses new funding opportunities for cannabinoid research.
Greenheart CBD

Greenheart CBD: A green crop from seed to shelf

Here, we learn how about a different kind of green crop that grows in Ireland and the journey of that from seed to shelf as part of the Greenheart CBD story.
attracting major investors, medicine

Attracting major investors: GreenLight on the international stage

In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.

The medical cannabis space: A successful targeted investment strategy

In this interview, David Engel from Full Moon Investments in the U.S., charts the firm’s successful targeted investment strategy – informed by industry-leading experience and expertise – including comments on the CBD hemp and medical cannabis space.
CBD capsules

Elixinol launches new UK range of blended, full-spectrum CBD capsules

Elixinol has launched a new UK range of blended, full-spectrum CBD capsules using six original combinations developed to support good health and wellbeing.
modulator of the endocannabinoid, biobloom

Essential oils as a potential modulator of the endocannabinoid system

Dr Christian Löfke, responsible for research and product development at BioBloom, walks us through the rudiments of essential oils as a potential modulator of the endocannabinoid system.
medicinal cannabis from Israel

The export of medicinal cannabis from Israel

Kathleen Denoodt shares with us what we need to know about the export of medicinal cannabis from Israel.

Cannabinoids in medicine part 5: Treating COVID-19

In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
novel food application, CBDepot

CBDepot: The company with a “Valid” Novel Food Application

Here, CBDepot discuss how they worked with the European Commission to achieve a “valid” Novel Food Application.

Follow Open Access Government